{"filing":{"accession_number":"0001356576-26-000028","cik":"0001356576","ticker":"SUPN","company_name":"SUPERNUS PHARMACEUTICALS, INC.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"supn-20260618.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1356576/000135657626000028/supn-20260618.htm"},"events":[{"id":11954,"run_id":10520,"accession_number":"0001356576-26-000028","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder vote results from Supernus Pharmaceuticals' June 18, 2026 annual meeting, including tabulated votes for four proposals: election of Class I directors, say-on-pay compensation approval, auditor ratification, and equity plan amendment. The filing directly matches Item 5.07 requirements and presents the definitive voting outcomes that are material to investors' understanding of corporate governance and shareholder sentiment.","company_name":"SUPERNUS PHARMACEUTICALS, INC.","ticker":"SUPN","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8676,"accession_number":"0001356576-26-000028","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Supernus Pharmaceuticals' June 18, 2026 annual meeting, including tabulated votes for four proposals: election of Class I directors, say-on-pay compensation approval, auditor ratification, and equity plan amendment. The filing directly matches Item 5.07 requirements and presents the definitive voting outcomes that are material to investors' understanding of corporate governance and shareholder sentiment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:58:06.034472+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8676,"accession_number":"0001356576-26-000028","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from Supernus Pharmaceuticals' June 18, 2026 annual meeting, including tabulated votes for four proposals: election of Class I directors, say-on-pay compensation approval, auditor ratification, and equity plan amendment. The filing directly matches Item 5.07 requirements and presents the definitive voting outcomes that are material to investors' understanding of corporate governance and shareholder sentiment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:58:06.034472+00:00","company_name":"SUPERNUS PHARMACEUTICALS, INC.","ticker":"SUPN","filing_date":"2026-06-18"}]}